AVNS vs CNMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CNMD Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CONMED Corporation (CNMD) driven by superior Valuation, Growth & Margin, Options & Structure while AVNS counters with relative strength in Momentum & Technical. Fundamentally, AVNS trades at 20.0x Forward P/E with 5.4% operating margin (+8.8% YoY revenue) versus CNMD at 10.7x Forward P/E and 10.2% operating margin (-0.7% YoY). In options structure, AVNS sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro) against CNMD sits in CONSOLIDATION (8th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AVNS | CNMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $1.5B | Larger Scale | CNMD |
| Trailing P/E Ratio Valuation | 30.7x | 20.9x | Lower Multiple | CNMD |
| Forward P/E Ratio Valuation | 20.0x | 10.7x | Lower Multiple | CNMD |
| Revenue Growth (YoY) Growth | +8.8% | -0.7% | Higher Growth | AVNS |
| Operating Margin (TTM) Profitability | 5.4% | 10.2% | Higher Margin | CNMD |
| Net Profit Margin Profitability | -10.4% | 5.4% | Higher Margin | CNMD |
| Return on Equity (ROE) Capital Efficiency | -9.2% | 7.1% | Higher ROE | CNMD |
| 52-Week Range Position Momentum | 97% ($9โ$25) | 77% ($31โ$55) | Stronger Trend | AVNS |
| Beta / 30D Volatility Risk Regime | 1.22ฮฒ ยท 6% Vol | 0.87ฮฒ ยท 61% Vol | Lower Realized Risk | AVNS |
| Unified Institutional Score Composite Signal | 56.7 / 100 (HOLD) | 37.0 / 100 (SELL) | Higher Composite | AVNS |